Scott A. Tetreault

Oncology
1600 Phillips Rd Ste 300
Tallahassee, FL 32308

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications

DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.

DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 12, 2019

'Economies of scale' yield multiple benefits for a private, physician-run oncology practice.

'Economies of scale' yield multiple benefits for a private, physician-run oncology practice.

Journal: Oncology (Williston Park, N.Y.)
Published: August 28, 2013
Showing 1-2 of 2

Last Updated: 09/26/2026